(Reuters) – The European Medicines Agency on Thursday authorised the use of AstraZeneca Plc’s antibody drug for preventing COVID-19 infections in adults and adolescents over 12 years of age.
(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)
